Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-10,000
Closed -$401K 942
2016
Q4
$401K Sell
10,000
-44,500
-82% -$1.72M 0.01% 612
2016
Q3
$2.12M Buy
54,500
+21,700
+66% +$819K 0.04% 197
2016
Q2
$1.14M Sell
32,800
-178,538
-84% -$6.18M 0.04% 311
2016
Q1
$7.29M Buy
211,338
+36,520
+21% +$1.27M 0.21% 99
2015
Q4
$6.76M Buy
174,818
+4,198
+2% +$163K 0.17% 98
2015
Q3
$6.68M Buy
170,620
+46,520
+37% +$1.84M 0.26% 97
2015
Q2
$4.72M Buy
+124,100
New +$4.34M 0.12% 154
2015
Q1
Sell
-37,900
Closed -$1.01M 723
2014
Q4
$1.01M Buy
+37,900
New +$978K 0.04% 324
2013
Q4
Sell
-98,800
Closed -$2.04M 572
2013
Q3
$2.04M Buy
+98,800
New +$2.1M 0.18% 100

Other funds holding HOLX

Hutchin Hill Capital's HOLX Position: Q1 2017 in Review

Hutchin Hill Capital sold out of Hologic (HOLX) in Q1 2017, closing a stake of 10,000 shares — an estimated $401K sold.

Hutchin Hill Capital first reported a position in HOLX in Q3 2013 and held it in 9 quarters. The position peaked at $7.29M in Q1 2016. 501 funds tracked by Wall St. Rank hold HOLX as of Q1 2017.

  • Hutchin Hill Capital reported no remaining Hologic position as of Q1 2017 after selling out during the quarter.
  • Hutchin Hill Capital sold 10,000 Hologic shares in Q1 2017, an estimated $401K.
  • Hutchin Hill Capital first reported a position in Hologic in Q3 2013 and held it in 9 quarters.
  • Hutchin Hill Capital's Hologic position peaked at $7.29M in Q1 2016.
  • 501 funds tracked by Wall St. Rank held Hologic as of Q1 2017.

Based on Hutchin Hill Capital's 13F filing for Q1 2017, filed 15 May 2017.